BridgeBio Pharma, Inc. (BBIO)
NASDAQ: BBIO · Real-Time Price · USD
76.80
-0.56 (-0.72%)
At close: Nov 17, 2026, 4:00 PM EST
76.76
-0.04 (-0.05%)
After-hours: Nov 17, 2026, 5:52 PM EST

BridgeBio Pharma Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
945.54502.08221.99.377.6569.72
Revenue Growth
167.27%126.26%2285.27%-88.02%11.38%745.14%
Gross Profit
892481.11218.026.8674.2166.6
Operating Income
-353.11-502.06-577.37-599.44-468.44-573.33
Net Income
-592.13-724.93-535.76-643.2-481.18-562.54
Earnings Per Share
-3.04-3.78-2.88-3.95-3.26-3.90
EPS Growth
------

Revenue by Segment

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period EndingSep '26 Dec '25 Dec '24 Dec '23
Net Product
802.4362.372.88359.48
License and Services
92.42128.32218.85-90.53
Royalty
50.7211.390.1711.22
Revenue (Total)
945.54502.08221.99.3

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1,539587.48681.1434.88471.92836.66
Total Debt
3,3781,8621,7311,7401,7241,726
Net Cash (Debt)
-1,839-1,275-1,049-1,305-1,252-889.51
Net Cash Growth
------
Net Cash Per Share
-9.43-6.66-5.64-8.02-8.49-6.16

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-368.97-445.91-520.73-527.72-419.49-497.93
Capital Expenditures
-0.84-1.1-0.93-1.31-4.82-13.25
Free Cash Flow
-369.81-447.01-521.66-529.03-424.32-511.18
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
94.34%95.83%98.25%73.71%95.58%95.53%
Operating Margin
-37.34%-100.00%-260.19%-6443.56%-603.28%-822.38%
Pretax Margin
-60.97%-145.89%-244.34%-7021.94%-624.17%-841.20%
Profit Margin
-62.62%-144.39%-241.44%-6913.92%-619.70%-806.90%
FCF Margin
-39.11%-89.03%-235.08%-5686.62%-546.46%-733.23%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
15.7529.3623.37754.9214.6735.22